In November 2025, the Trump Administration announced an upcoming demonstration project that will extend coverage for GLP-1s to people living with obesity and related complications starting later in 2026
E., Dalton, B
Taste receptor-like cells in the rat gut identified by expression of alpha-gustducin
Restless legs syndrome (RLS), which is also known as Willis-Ekbom disease, is a common neurological sleep and movement disorder that causes an uncontrollable urge to move the legs because of itching, kicking, or crawling sensations in the legs, according to the Mayo Clinic
Pharmacogenomics Test PGx (Prescription Medicines) Personalised medicine has the potential to save lives and reduce adverse medication reactions
For those using injectable compounds, the peptide injections guide covers technique, while the dosage calculation guide and peptide dosage chart ensure accuracy